(Karolinska Institutet) A thyroid-hormone-like substance that works specifically on the liver reduces blood cholesterol with no serious side effects. This according to a clinical trial conducted by researchers from the Swedish medical university Karolinska Institutet, amongst other centers, published today in the top-ranking scientific periodical the New England Journal of Medicine.
Read »Navigation
User login
Visit the BiotechMashup Blog
Best upcoming scoops - Medicine
- Cellular Growth Kinetics Distinguish a Cyclophilin Inhibitor from an HSP90 Inhibitor as a Selective Inhibitor of Hepatitis C Vir
- Differences in Acinetobacter baumannii Strains and Host Innate Immune Response Determine Morbidity and Mortality in Experimental
- Circular RNAs Are the Predominant Transcript Isoform from Hundreds of Human Genes in Diverse Cell Types
- Two-Item Sentence Comprehension by a Dog (Canis familiaris)
- Risks of pregnancy via egg donation similar for women over age 50 as for younger women